Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Oncology|June 24, 2022
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?Lucia Bortot, Giada Targato, Claudia Noto, et al.
NPJ Breast Cancer|December 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancerLinda Cucciniello, Eva Blondeaux, Claudia Bighin, et al.
Scientific Reports|February 28, 2024
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective studyLucia Fratino, Jerry Polesel, Emilio Francesco Giunta, et al.
Translational Oncology|June 27, 2025
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomicsLorenzo Foffano, Alessandra Franzoni, Elisabetta Molteni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 26, 2023
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO networkEmilio Francesco Giunta, Silvia De Padova, Shobana Anpalakhan, et al.
The Oncologist|August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO NetworkPasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
Critical Reviews in Oncology/Hematology|June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
Cancer Treatment Reviews|October 22, 2024
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus projectStefania Gori, Fiorenza De Rose, Antonella Ferro, et al.
Pageof 2